Begin main content

Combination Inhaled Corticosteroids and Long-Acting Beta2-Agonists for Acute Respiratory Tract Infections and Cough: A Review of the Clinical Effectiveness

Last updated: July 6, 2016
Project Number: RC0790-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Summary with Critical Appraisal
Result type: Report

Question

  1. What is the clinical effectiveness of combination inhaled corticosteroids (ICSs) and long-acting beta2-agonists (LABAs) for patients with acute bacterial upper respiratory tract infections?
  2. What is the clinical effectiveness of combination ICSs and LABAs for patients with acute viral upper respiratory tract infection?
  3. What is the clinical effectiveness of combination ICSs and LABAs for patients with post-infectious or subacute cough?
  4. What is the clinical effectiveness of combination ICSs and LABAs for patients with chronic cough?
  5. What is the clinical effectiveness of combination ICSs and LABAs for patients with cough in sarcoidosis?

Key Message

The literature search for this review did not find any studies that evaluated the clinical effectiveness of combination ICSs and LABAs for patients with acute bacterial or viral upper respiratory tract infections, post-infectious or subacute cough, chronic cough, or cough in sarcoidosis.